Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DEFT
2751
Defi Technologies
DEFT
$153M
| $1.75M | ﹤0.01% |
3,162,432
-4,166,852
| -57% | -$3.18M |
|
2752
Inhibrx
INBX
$1.2B
| $1.73M | ﹤0.01% |
25,671
-1,670
| -6% | -$124K |
|
2753
Lyell Immunopharma
LYEL
$309M
| $1.72M | ﹤0.01% |
85,971
+548
| +0.6% | +$12.8K |
|
|
NXDT
2754
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $1.71M | ﹤0.01% |
366,325
-6,119
| -2% | -$27.4K |
|
2755
Shore Bancshares
SHBI
$790M
| $1.71M | ﹤0.01% |
91,496
+2,325
| +3% | +$43.3K |
|
2756
Outdoor Holding Co
POWW
$239M
| $1.7M | ﹤0.01% |
847,771
+28,386
| +3% | +$54K |
|
2757
Eton Pharmaceutcials
ETON
$1.17B
| $1.7M | ﹤0.01% |
68,795
-8,417
| -11% | -$147K |
|
2758
Alector
ALEC
$164M
| $1.69M | ﹤0.01% |
787,408
+121,917
| +18% | +$245K |
|
2759
ICL Group
ICL
$6.81B
| $1.68M | ﹤0.01% |
324,013
+134,548
| +71% | +$720K |
|
2760
Mama's Creations
MAMA
$825M
| $1.68M | ﹤0.01% |
109,324
+2,547
| +2% | +$38.7K |
|
|
ARDT
2761
Ardent Health
ARDT
$1.53B
| $1.67M | ﹤0.01% |
195,571
-6,913
| -3% | -$62K |
|
2762
Distribution Solutions Group
DSGR
$1.6B
| $1.67M | ﹤0.01% |
63,795
-2,603
| -4% | -$72.8K |
|
2763
Arcturus Therapeutics
ARCT
$157M
| $1.67M | ﹤0.01% |
216,500
+32,645
| +18% | +$238K |
|
|
PTRN
2764
Pattern Group Inc
PTRN
$3.92B
| $1.67M | ﹤0.01% |
134,177
+960
| +0.7% | +$11.8K |
|
2765
Anika Therapeutics
ANIK
$199M
| $1.66M | ﹤0.01% |
114,399
+8,102
| +8% | +$94K |
|
2766
EverCommerce
EVCM
$2.05B
| $1.66M | ﹤0.01% |
145,081
-3,392
| -2% | -$38.5K |
|
2767
Simulations Plus
SLP
$371M
| $1.62M | ﹤0.01% |
137,397
-13,589
| -9% | -$200K |
|
2768
Mitek Systems
MITK
$762M
| $1.6M | ﹤0.01% |
118,250
-78,338
| -40% | -$969K |
|
2769
Lennar Class B
LEN.B
$20B
| $1.59M | ﹤0.01% |
18,959
-9,988
| -35% | -$1.01M |
|
2770
Kodak
KODK
$806M
| $1.59M | ﹤0.01% |
175,985
+19,998
| +13% | +$153K |
|
2771
UroGen Pharma
URGN
$2B
| $1.59M | ﹤0.01% |
88,466
-2,523
| -3% | -$50.6K |
|
|
RNA
2772
Atrium Therapeutics
RNA
$197M
| $1.56M | ﹤0.01% |
+116,598
| New | +$1.64M |
|
2773
Holley
HLLY
$314M
| $1.56M | ﹤0.01% |
507,051
-16,156
| -3% | -$61.2K |
|
|
OMDA
2774
Omada Health Inc
OMDA
$1.22B
| $1.55M | ﹤0.01% |
123,707
+50,385
| +69% | +$696K |
|
2775
AXT Inc
AXTI
$3.09B
| $1.55M | ﹤0.01% |
27,137
+7,122
| +36% | +$236K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.